Standard Operating Procedure (SOP) for the Analytical Phase of
Generating Results for MAYOCOMPLETE CHRONIC LYMPHOID
NEOPLASMS, NEXT-GENERATION SEQUENCING
1. PURPOSE
To provide a standardized protocol for the analytical phase of
generating results for the MAYOCOMPLETE Chronic Lymphoid
Neoplasms, Next-Generation Sequencing (NGS) test, ensuring
accuracy, reliability, and reproducibility of test results.
2. SCOPE
This SOP applies to all staff involved in the NGS testing for chronic
lymphoid neoplasms.
3. RESPONSIBILITY
• Laboratory Technologists: Perform all procedures involved in the
analytical phase.
• Laboratory Supervisors: Ensure all procedures are followed
correctly and address any inconsistencies or issues.
• Quality Assurance (QA) Personnel: Monitor compliance with SOP
and regulatory requirements.
4. MATERIALS and EQUIPMENT
• NGS Sequencing Instrument (e.g., Illumina MiSeq, NextSeq)
• DNA Extraction Kits
• Library Preparation Kits
• Barcoded Adapters
• Pipettes and Tips
• Thermal Cycler
• Magnetic Stand
• Multichannel Pipette
• Qubit Fluorometer
• Bioanalyzer or TapeStation
• PCR Plates and Tubes
• Reagents and Consumables specific for the assay
• Laboratory Information Management System (LIMS)
5. PROCEDURE
5.1 DNA Extraction
• Extract DNA from blood or bone marrow samples using
designated DNA Extraction Kits.
• Quantify DNA using Qubit Fluorometer and document
concentration.
• Assess DNA quality using Bioanalyzer or TapeStation.
5.2 Library Preparation
• Perform library preparation using designated kits following
manufacturer's instructions.
• Include positive and negative controls in each batch.
• Use barcoded adapters to differentiate samples.
• Ensure all reagents and samples are mixed thoroughly using a
vortex and centrifugation as necessary.
• Amplify libraries using PCR and appropriate thermal cycling
conditions.
5.3 Library Quantification and Quality Check
• Quantify the prepared libraries using Qubit Fluorometer.
• Assess library quality and size distribution using Bioanalyzer or
TapeStation.
• Normalize libraries to the required concentration for sequencing.
5.4 Sequencing
• Load libraries into the sequencing instrument according to the
manufacturer's protocol.
• Ensure correct setup and configuration of the sequencing run.
• Monitor sequencing run for any issues and perform
troubleshooting as needed.
5.5 Data Analysis
• Upon completion of the sequencing run, transfer raw sequencing
data to the bioinformatics team.
• Perform initial data quality checks including read counts, quality
scores, and sequence alignment.
• Process data through the appropriate bioinformatics pipeline to
identify genetic variants.
• Annotate variants using clinical databases and tools.
5.6 Data Interpretation and Reporting
• Review data interpretation guidelines specific to chronic lymphoid
neoplasms.
• Correlate identified variants with known clinical significance.
• Draft a comprehensive report summarizing findings.
• Include recommended follow-up actions if applicable.
• Review and sign off reports by qualified personnel.
5.7 Quality Control and Assurance
• Run external and internal controls in each batch of tests to ensure
accuracy.
• Document and track all steps in LIMS.
• Perform routine maintenance and calibration of the sequencing
instrument.
• Review and address any deviations or anomalies from the SOP.
• Maintain a log of any corrective actions taken.
6. REFERENCES
• Manufacturer's instructions for DNA Extraction Kits, Library
Preparation Kits, and Sequencing Instruments.
• Published clinical guidelines for chronic lymphoid neoplasms.
• Laboratory Handbook and Quality Manual
7. DOCUMENTATION
• Ensure complete documentation of:
◦ DNA concentration and quality assessment
◦ Library preparation steps and quantification
◦ Sequencing run parameters and issues
◦ Data analysis results
◦ Final reports and interpretations
◦ Quality control measures and corrective actions
8. REVISION HISTORY
• Initial Release: October 2023
• Any subsequent revisions to be documented with date, changes
made, and personnel responsible.
This SOP ensures the standardized processing of samples for the
MAYOCOMPLETE Chronic Lymphoid Neoplasms, Next-Generation
Sequencing test, maintaining high standards of precision and
accuracy in the generation and reporting of results.